DOJ letters to peer-reviewed journals allege partisan bias in medical literature

After a year-long reign over tumult at FDA, Makary heads for the exit
Fruit-flavored e-cigs were the final blow for the commissioner

The immediate impetus for FDA Commissioner Marty Makary’s exit from the top job at FDA is arguably less significant than the legacy of dysfunction he leaves behind.

May 15, 2026

Vol.52 No.19

By Claire Marie Porter

Cancer Policy

Trump changes pick for Surgeon General, nominating Nicole Saphier

President Donald Trump has withdrawn the nomination of Casey Means for Surgeon General, instead nominating Nicole B. Saphier, a radiologist at Memorial Sloan Kettering Cancer Center.

May 08, 2026

Vol.52 No.18

By Claire Marie Porter

Podcast

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

The Cancer Letter’s coverage of HHS-led overhauls of foundational scientific institutions continued last week with two unrelated stories pointing to continued disarray amongst public health leadership.

May 06, 2026

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

Health and Human Services Secretary Robert F. Kennedy Jr. is moving to overhaul the U.S. Preventive Services Task Force, a highly influential panel that determines which preventive services insurers must cover and guides routine medical care for millions of Americans.

May 01, 2026

Vol.52 No.17

By Claire Marie Porter

Cancer Policy

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, or ACIP, voted in December to rescind its recommendation that all newborns receive a hepatitis B virus vaccine dose within 24 hours of birth.

May 01, 2026

Vol.52 No.17

By Claire Marie Porter

Cancer Policy

Kennedy hints at intended USPSTF reforms at Senate Finance Committee hearing

At the Senate Finance Committee hearing on April 22, Health and Human Services Secretary Robert F. Kennedy Jr. hinted at how he intends to reform the U.S. Preventive Services Task Force, a highly respected, independent organization that weighs evidence to make recommendations on screening for diseases.

April 24, 2026

Vol.52 No.16

By Claire Marie Porter

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

YOU MAY BE INTERESTED IN

After a year-long reign over tumult at FDA, Makary heads for the exit
Fruit-flavored e-cigs were the final blow for the commissioner

Trump changes pick for Surgeon General, nominating Nicole Saphier

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

Kennedy hints at intended USPSTF reforms at Senate Finance Committee hearing

Renew today!

Subscriber content

Never miss an issue!

Login

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

YOU MAY BE INTERESTED IN

After a year-long reign over tumult at FDA, Makary heads for the exitFruit-flavored e-cigs were the final blow for the commissioner

Trump changes pick for Surgeon General, nominating Nicole Saphier

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panelRansohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

Kennedy hints at intended USPSTF reforms at Senate Finance Committee hearing

Never miss an issue!

Login

After a year-long reign over tumult at FDA, Makary heads for the exit
Fruit-flavored e-cigs were the final blow for the commissioner

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”